Dimitrios H Roukos. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/administration & dosageAntineoplastic Agents/therapeutic useBreast Neoplasms/drug therapyBreast Neoplasms/geneticsBreast Neoplasms/pathologyDrug Resistance, Neoplasm/drug effectsFemaleGene Regulatory NetworksGenome, HumanHumansModels, GeneticMolecular Sequence DataMutationPharmacogenetics/methodsReceptor, ErbB-2/geneticsStomach Neoplasms/drug therapyStomach Neoplasms/geneticsStomach Neoplasms/pathologyTrastuzumab
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsERBB2 protein, humanReceptor, ErbB-2Trastuzumab
Year: 2010 PMID: 20704462 DOI: 10.2217/pgs.10.104
Source DB: PubMed Journal: Pharmacogenomics ISSN: 1462-2416 Impact factor: 2.533